不同剂量熊果酸干预糖尿病小鼠视网膜病变的作用及机制研究

目的:探究不同剂量熊果酸(UA)干预糖尿病小鼠视网膜病变的作用及机制。方法:选取雄性健康C57BL/6小鼠60只,其中50只按50 mg/kg的剂量一次性往小鼠尾静脉注射新鲜配置的四氯嘧啶生理盐水溶液构建小鼠糖尿病视网膜病变模型,随机分为5组,每组10只,分别为模型组、阳性对照组(小鼠玻璃体注射3μL 40 mg/m L的曲安奈德),低剂量UA干扰组(小鼠玻璃体注射3μL剂量为0.5μg/μL的UA)、中剂量UA干扰组(小鼠玻璃体注射3μL剂量为1.0μg/μL的UA),高剂量UA干扰组(小鼠玻璃体注射3μL剂量为2.0μg/μL的UA),余下10只小鼠作为正常对照组。观察各组小鼠对胰岛素敏感性、视网膜内糖代谢情况、小鼠视网膜神经节细胞(RGCs)凋亡情况,比较各组小鼠视网膜组织中血管内皮生长因子(VEGF)、环氧化酶-2(COX-2)、基质金属蛋白酶2(MMP-2)蛋白及其mRNA的表达情况。结果:建模后,正常对照组胰岛素抵抗指数(HOMA-IR)、视网膜含糖量、葡萄糖转运体-1(GLUT-1)与葡萄糖转运体-3(GLUT-3)含量、RGCs凋亡率、视网膜组织中VEGF、COX-2、MMP-2蛋白及其mRNA的表达量低于模型组(P0.05);经干扰后,阳性对照组、不同剂量UA干扰组HOMA-IR、视网膜含糖量、GLUT-1、GLUT-3的含量、RGCs凋亡率、视网膜组织中VEGF、COX-2、MMP-2蛋白及其mRNA的表达量低于模型组(P0.05),且随UA干扰剂量的升高而降低(P0.05)。结论:UA能够降低HOMA-IR和视网膜糖代谢能力,抑制RGCs的凋亡,对VEGF、COX-2、MMP-2蛋白及其mRNA的表达具有一定的抑制作用,高剂量UA对糖尿病小鼠视网膜病预防治疗效果较好。     

枸杞多糖对糖尿病大鼠视网膜神经元的保护作用及其机制

目的:观察枸杞多糖(LBP)对糖尿病大鼠视网膜神经细胞的保护作用,并探讨其作用机制。方法:18只SD大鼠随机分为3组(n=6):正常对照组(NC),糖尿病模型组(DM)和LBP治疗组(DM+LBP),通过一次性腹腔注射链脲佐菌素(STZ)的方法制备糖尿病大鼠模型。DM+LBP组按1 mg/(kg·d)剂量的LBP灌胃12周。治疗结束后检测大鼠体重、空腹血糖、视网膜活性氧簇(ROS)的生成、视网膜神经节细胞(RGCs)和无长突细胞的表达、视网膜NF-E2相关因子2(Nrf2)和血红素加氧酶-1(HO-1)的蛋白表达。结果:STZ诱导糖尿病大鼠模型造模成功率100%。与NC组相比,DM组大鼠体重明显降低、空腹血糖值升高、ROS的生成明显增加、RGCs和无长突细胞的数量均明显减少(P<0.01)。与DM组相比,LBP治疗组大鼠体重升高、血糖降低、ROS的生成减少、RGCs和无长突细胞的数量均明显增加(P<0.01或P<0.05);视网膜Nrf2和HO-1的蛋白表达均明显升高(P<0.01)。结论:LBP能改善糖尿病大鼠视网膜的氧化应激状态,对糖尿病大鼠视网膜神经细胞有一定的保护效应,其作用机制可能与其激活Nrf2/HO-1信号通路有关。     

牛磺酸抑制糖尿病大鼠视网膜Muller细胞VEGF表达的研究

目的:进一步了解糖尿病引起视网膜受损的分子机制、探讨牛磺酸保护糖尿病大鼠视网膜损伤的可能机制.方法用链脲佐茵素诱导SD大鼠患糖尿病,分为正常对照组、糖尿病组、1%牛磺酸干预糖尿病组、5%%牛磺酸干预糖尿病组、胰岛素治疗糖尿病组.正常对照组、糖尿病组、胰岛素治疗组饲以基础饲料,牛磺酸干预组饲以基础饲料分别添加1%、5% 牛磺酸的饲料喂养,胰岛素治疗组每天皮下注射20U/kg胰岛素.在第2周、1月、2月、3月取视网膜,用RT-PCR、免疫组织荧光化学、Western-blotting检测视网膜Muller细胞VEGFmRNA和蛋白表达情况.结果:经链脲佐菌素诱导惠糖尿病2周后,SD大鼠视网膜Muller细胞VEGFmRNA和蛋白表达增加,且随病程的延长表达量有持续增加趋势(P＜0.05).患糖尿病3月后,整个视网膜中VEGF免疫染色明显增强,尤以外网状层(OPL)、内网状层(IPL)和视网膜外段变化最明显.牛磺酸干预糖尿病1月后.大鼠视网膜Muller细胞VEGFmRNA和蛋白的表达下调(P＜0.05).结论:牛磺酸抑制糖尿病患者视网膜Muller细胞VEGF的表达,减轻糖尿病引起的视网膜损害.     

骨钙素减轻糖尿病大鼠血- 视网膜屏障的损伤

目的:研究骨钙素(Osteocalcin)对链脲佐菌素诱导的糖尿病大鼠血-视网膜屏障的影响。方法:取健康SD大鼠24只,随机分为正常对照组、糖尿病1月(DM1)组、糖尿病骨钙素干预(DM1+OCGY)组。尾静脉注射STZ建立DM模型,成模后DM1+OCGY组腹腔注射骨钙素(2.57 mg.kg-.1d-1),DM1组腹腔注射等量生理盐水,1个月后处死动物。用伊文思蓝方法检测大鼠血-视网膜屏障的改变。结果:造模1月后大鼠视网膜血管渗透性显著增加,共聚焦显微镜显示红色荧光斑点主要分布在视网膜血管周围,给予骨钙素后,红色荧光斑点明显减少,进一步定量显示1M糖尿病大鼠视网膜伊文思蓝含量为57.4±8.7μg.g-1,骨钙素能够改变这种变化,DM1+OCGY组伊文思蓝含量为26.1±3.8μg.g-1。结论:骨钙素能抑制糖尿病视网膜病的血管渗漏,对糖尿病引起的血-视网膜屏障破坏有保护作用。     

米诺环素对糖尿病大鼠视网膜神经细胞凋亡的影响

目的:观察米诺环素对糖尿病大鼠视网膜神经细胞的凋亡的影响,研究米诺环素对糖尿病视网膜神经保护作用,对米诺环素在糖尿病视网膜疾病中抑制神经细胞凋亡提供理论支持。方法:选择健康成年雄性SD大鼠30只,随机分成正常对照组、糖尿病模型组和米诺环素治疗组,每组10只。腹腔内注射链脲佐菌素(STZ)诱发大鼠糖尿病。米诺环素治疗组给予米诺环素腹腔注射(45mg/kg),共注射10d,模型组和对照组腹腔注射等体积生理盐水,于给药后8周的3组动物处死,冰浴下取其视网膜组织,随后制备视网膜石蜡切片,采用末端脱氧核糖核酸介导生物素化脱氧尿嘧啶缺口末端标记(TUNEL)法进行凋亡细胞原位标记,行视网膜神经细胞凋亡计数,对所有数据进行统计学分析。实验结果拟用均数和标准差(x±s)表示,P<0.05为差异有统计学意义。结果:相同观察时相,与阴性对照组比较,模型对照组大鼠视网膜TUNEL阳性细胞显著增多(P<0.01),在米诺环素组,大鼠视网膜TUNEL阳性细胞数比模型对照组明显减少,差异有统计学意义(P<0.01)。结论:米诺环素能有效降低糖尿病大鼠视网膜神经细胞的凋亡,对糖尿病视网膜神经细胞有保护作用。     

糖尿病视网膜病变患者内皮祖细胞的数量变化分析

目的:研究糖尿病视网膜病变患者内皮祖细胞(EPCs)的数量变化,从而探讨内皮祖细胞是否参与了糖尿病微血管病并发症的发生发展。方法:选择与年龄、性别相匹配的患者,共124例,其中健康对照组62例,单纯糖尿病组31例(DM组),糖尿病背景期视网膜病变15例(DM+NPDR组),糖尿病增殖期视网膜病变组16例(DM+PDR组)。采用密度梯度离心法从人外周血分离出单个核细胞,通过流式细胞仪检测内皮祖细胞数量。结果:与健康对照组相比,DM组、DM+NPDR组、DM+PDR组的外周血EPCs的数量明显减少(P0.05)。DM+NPDR组与DM组相比,外周血EPCs数量无统计学差异(P0.05)。DM+PDR组与DM组相比,外周血EPCs数量显著增加(P0.05)。结论:EPCs参与了糖尿病微血管并发症的发生发展,有望在临床治疗中成为潜在的治疗靶点。     

早期糖尿病大鼠视网膜中血管生成素-1、血管内皮生长因子的表达

目的:研究血管生成素-1(angiopoietin-1,Ang-1)和血管内皮生长因子(vascular endothelial growth factor,VEGF)在早期糖尿病大鼠视网膜中的表达及其意义。方法:制备类似人类Ⅰ型糖尿病大鼠动物模型,取40只SD雄性大鼠分糖尿病组28只及正常对照组12只,糖尿病组28只SD雄性大鼠腹腔注射STZ65mg.Kg-1,建模成功后分别在1周、2周、3周、4周各取糖尿病组7只及正常对照组3只摘取大鼠眼球,应用免疫组化法检测Ang-1、VEGF在视网膜中的表达。结果:Ang-1、VEGF在正常大鼠视网膜的染色均为阴性,Ang-1在1、2、3周糖尿病大鼠视网膜内界膜、内核层及散在血管旁周细胞及Mǔller细胞中呈阳性表达,4周时呈阴性染色反应,Ang-1在糖尿病大鼠视网膜中表达1周阳性率约为39.5%,2周阳性率约为59.7%,3周阳性率约为78.9%,4周阳性率约为19.0%。VEGF在糖尿病大鼠视网膜中表达1周阳性率约为38.6%,2周阳性率约为54.3%,3周阳性率为78.9%,4周阳性率约为42%。结论:Ang-1、VEGF可能在糖尿病视网膜病变早期形成中起到重要...     

胰岛素对糖尿病大鼠下颌下腺Bcl-2和Caspase-3表达的影响及意义

目的观察胰岛素对糖尿病大鼠下颌下腺内凋亡相关蛋白Bcl-2和Caspase-3表达的影响。方法 SD大鼠30只,随机分为3组,10只大鼠作为对照组(C);10只大鼠用链尿佐菌素复制糖尿病模型作为DM组;10只大鼠用链尿佐菌素复制糖尿病模型,予以胰岛素治疗作为INS组。2个月后取血检测血糖、血脂;取大鼠下颌下腺,分别进行免疫组织化学显色(SP法)和计算机图像分析系统测平均光密度。结果①血糖检测结果:C组和INS组的血糖分别与DM组血糖比较,均有差异(P0.05);②血脂检测结果:C组和INS组的TG分别与DM组TG比较,均有显著性差异(P0.05);DM组TC分别与C组和INS组TC比较,均有显著性差异(P0.05)。③免疫组化结果:与C组比较,DM组大鼠下颌下腺导管上皮细胞内Bcl-2表达显著下降(P0.05),Caspase-3表达显著增加(P0.05);与DM组比较,胰岛素组Bcl-2表达显著增加(P0.05),Caspase-3表达显著下降(P0.05)。结论 DM大鼠下颌下腺内Bcl-2表达降低和Caspase-3表达增加,可能在糖尿病时下颌下腺细胞凋亡过程中发挥重要作用,而胰岛素具有对抗糖尿病下颌下腺细胞凋亡的作用。     

2型糖尿病大鼠心肌IR、IRS-1的表达与罗格列酮及APP5肽类似物P165的干预效应

目的研究2型糖尿病大鼠心肌胰岛素信号转导通路蛋白胰岛素受体（IR）、胰岛素受体底物-1（IRS-1）的表达与正常SD大鼠的区别,并探讨进行罗格列酮及APP5肽类似物P165干预后对上述蛋白表达的影响。方法60只SD大鼠随机分为正常对照组（C组）、正常对照＋罗格列酮组（C＋RSG组）、2型糖尿病组（T2DM组）、2型糖尿病＋罗格列酮组（T2DM＋RSG组）、糖尿病给予P165小剂量组（T2DM＋P165小剂量组）、糖尿病给予P165大剂量组（T2DM＋P165大剂量组）,其中糖尿病动物采用高脂饮食后给予小剂量STZ腹腔注射的方法造模。后将各组SD大鼠处死,采用免疫组织化学染色和Western blot的方法检测心肌组织IR、IRS-1的表达。结果（1）2型糖尿病组（T2DM组）心肌组织IR、IRS-1的表达水平显著低于对照组（C组）;（2）2型糖尿病＋罗格列酮组（T2DM＋RSG组）心肌组织IR、IRS-1的表达水平显著高于T2DM组;（3）免疫组化染色发现2型糖尿病＋P165小/大剂量组（T2DM＋P165小/大剂量组）心肌组织IR、IRS-1免疫反应阳性颗粒沉着的累积光密度值显著高于T2DM组;Western blot结果显示T2DM＋P165小/大剂量组心肌组织IRS-1的表达水平显著高于T2DM组;而IR的表达水平与T2DM组相比无差别。结论（1）2型糖尿病大鼠心肌存在胰岛素抵抗或信号转导障碍;（2）罗格列酮干预后可以改善2型糖尿病心肌的胰岛素信号转导异常;（3）P165对2型糖尿病大鼠心肌胰岛素信号转导具有调节作用,其作用靶点可能为胰岛素受体底物。     

C肽对糖尿病大鼠肾脏的影响

比较C肽和胰岛素对大鼠糖尿病肾病的治疗作用。方法:选取Wistar大鼠40只,分为正常对照组(NG组)和糖尿病组(DM组),糖尿病组链脲佐菌素诱发大鼠成模后,随机分为三组:糖尿病组(DM组)、胰岛素组(IG组)和C肽组(ICG组)。治疗8周后测定各组大鼠24小时尿白蛋白排泄率(UAER)、肾重/体重,并观察糖尿病大鼠肾脏超微结构变化。结果:24小时尿白蛋白排泄率:糖尿病组明显增加,C肽组明显低于糖尿病组和胰岛素组,差异具有显著性。大鼠肾脏超微结构变化:各组大鼠肾小球截面积、肾小球平均体积(MGV)、细胞外基质/肾小球截面积比值、细胞外基质截面积、肾小球基底膜厚度相比,糖尿病组明显升高,C肽组较胰岛素组和糖尿病组明显下降,差异具有显著性。结论:C肽治疗可以降低24小时尿白蛋白排泄率,改善糖尿病大鼠肾脏超微结构病变。     

Effects of VEGF(165) and VEGF(121) on vasculogenesis and angiogenesis in cultured embryonic quail hearts

It has been documented that hypoxia enhances coronary vasculogenesis and angiogenesis in cultured embryonic quail hearts via the upregulation of vascular endothelial growth factor (VEGF). In this study, we compared the functions of two VEGF splice variants. Ventricles from 6-day-old embryonic quail hearts were cultured on three-dimensional collagen gels. Recombinant human VEGF(121) or VEGF(165) were added to the culture medium for 48 h, and vascular growth was visualized by immunostaining with a quail-specific endothelial cell (EC) marker, QH1. VEGF(165) enhanced vascular growth in a dose-dependent manner: 5 ng/ml of VEGF(165) slightly increased the number of ECs, 10 ng/ml of VEGF(165) increased the incorporation of ECs into tubular structures, and at 20 ng/ml of VEGF(165) wider tubes were formed. This pattern plateaued at the 50 ng/ml dose. In contrast, VEGF(121) did not enhance either the number of ECs or tube formation at these or higher dosages. Combined effects of hypoxia and exogenous VEGF(165) were then compared. Tube formation from the heart explants treated with both hypoxia and 50 ng/ml of VEGF(165) had a morphology intermediate to those treated with hypoxia or VEGF(165) alone. Immunocytochemistry study revealed EC lumenization under all culture conditions. However, the addition of VEGF(165) stimulated the coalescence of ECs to form larger vessels. We conclude the following: 1) VEGF(121) and VEGF(165) induced by hypoxia have different functions on coronary vascular growth, 2) unknown factors induced by hypoxia can modify the effect of VEGF(165), and 3) EC lumenization observed in the heart explant culture closely mimics in vivo coronary vasculogenesis.     

Ultrastructural and proliferative features of the ventral lobe of the prostate in non-obese diabetic mice (NOD) following androgen and estrogen replacement associated to insulin therapy

Diabetes causes harmful effects on prostatic function. Thus, the aims of this study were to characterize morphological and proliferative features of the prostate of diabetic mice after long-term glycemic control and testosterone and estrogen replacement. A total of 48 mice (Nod and BALBc) were used. After 20 days in a diabetic state, the mice were divided into six groups: the control group received a 5 mL/kg dose of peanut oil; the diabetic group received the same treatment as the control group; the diabetic-insulin group received 4 IU doses of insulin; the diabetic-testosterone group received a 5 mg/kg dose of testosterone cypionate; the diabetic-estrogen group received a 25 μg/kg dose of 17β-estradiol; the diabetic-insulin-testosterone-estrogen group received insulin, testosterone and estrogen at the same concentration as the other groups. After 20 days, the ventral lobe was processed for morphological and immunological analyses. The results showed structural disorganization, which was more intense in the diabetic group than in the other groups. The diabetic state showed a proliferation and apoptosis rate that was two times higher than that found in the control group. To conclude, diabetes disturbed the prostatic secretory activity and the association of insulin, testosterone and estrogen was crucial for glandular structural restoration, characterizing the complex activity of the prostate. The imbalance verified between the proliferation process and apoptosis in diabetic mice showed diabetes to be a triggering factor for prostatic pathogenesis.     

Effect of Total Suspended Particulate Matter in the Air on Inflammation Factors and Apoptotic Markers in Diabetic Rats: The Protective Effect of Insulin and Crocin

Background:The effect of total suspended particulate matter (TSP) was investigated on the expression of inflammatory and apoptotic factors in diabetic rats, and the effect of crocin and insulin was examined on these factors.Methods:Fifty-four adult male wistar rats were divided into nine experimental groups: control group, crocin group (received crocin, 50 mg/kg), diabetic group (received a single dose of alloxan at 120 mg/kg, IP), TSP group (5 mg/kg TSP instilled intratracheally), diabetic-crocin group (received crocin at 50 mg/kg after the induction of diabetes by alloxan (120 mg/kg)), diabetic-insulin group (received regular insulin (5 U/kg), crocin-TSP group (received crocin at 50 mg/kg, IP, and then 5 mg/kg TSP was instilled intratracheally), diabetic-TSP-insulin group (after receiving alloxan (120 mg/kg) and instilling TSP (5 mg/kg, intratracheally), a single dose (5 U/kg) of regular insulin), and diabetic-TSP-crocin group (after receiving alloxan (120 mg/kg) and instilling TSP (5 mg/kg, intratracheally), a single dose of crocin (50 mg/kg, IP)). Quantitative real-time PCR was performed to measure the expression of the mRNAs of apoptotic (Bax and Bcl2) and inflammatory mediators (TNFα, COX2, iNOS/eNOS) in Wistar rats.Results:In diabetic and TSP groups the inflammatory factors and BAX/Bcl2 ratio significantly increased compared to the control group. In diabetic-TSP-insulin and diabetic-TSP-crocin, a significant decrease was observed in the rate of inflammatory factors and BAX/Bcl2 ratio.Conclusion:The results suggested that diabetes and exposure to TSP increase the rate of apoptosis and inflammation, and also demonstrated the anti-apoptotic and anti-inflammation role of insulin and crocin.Key Words: Apoptosis, Crocin, Diabetes, Inflammation, Insulin, TSP     

川芎嗪联合氨胍治疗对糖尿病大鼠视网膜血管内皮生长因子表达的影响

目的 观察川芎嗪联合氨胍治疗对糖尿病大鼠视网膜血管内皮生长因子（VEGF）表达的影响。探讨川芎嗪联合氨胍治疗糖尿病视网膜病变（DR）的机制。方法 应用链尿佐菌素（STZ）制作糖尿病大鼠模型。分为正常对照组,糖尿病未治疗组,川芎嗪治疗组,氨胍治疗组和川芎嗪联合氨胍治疗组,分别于第4周,第12周和第20周应用免疫组化方法观察各组大鼠视网膜组织VEGF表达的变化。结果 正常大鼠视网膜组织VEF表达仅见于内核层,糖尿病大鼠视网膜组织VEGF阳性表达随周龄的延长而增强,且在毛细血管内和节细胞层可见VEGF表达,治疗12周和20周后,川芎嗪治疗组和氨胍治疗组大鼠视网膜组织VEGF阳性表达比未治疗组明显减弱,但仍高于正常对照组,而川芎嗪联合氨胍治疗组视网膜组织VEGF表达接近正常。结论 川芎嗪联合氨胍治疗可抑制糖尿病大鼠视网膜VEGF的过度表达。是川芎嗪联合氨胍治疗糖尿病视网膜病变（DR）的机制之一。     

Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart

Cardiovascular complications are an important feature of diabetes mellitus (DM). Abnormal and decreased coronary collateral development has been implicated in the pathogenesis of cardiac complications in DM. More recently, decreased expression of vascular endothelial growth factor (VEGF) and its receptors has been found in diabetic heart. To our knowledge, no study has focused on the therapeutic improvement associated with VEGF in diabetic heart. DM was induced by intraperitoneal injection of streptozotocin (65 mg/kg) in Sprague-Dawley rats, while control rats received only citrate buffer. After 1 week, the streptozotocin-treated rats were randomly divided into two groups: one group received the selective endothelin (ET) type A receptor antagonist TA-0201 at a dose of 1 mg/kg/day for 2 weeks by osmotic mini-pump, and the vehicle group received saline only. The plasma glucose level was 504 +/- 75 mg/dl in the diabetic rats and was unchanged by treatment with ET antagonist. The body weight was decreased in the diabetic rats compared with the control rats, but the left ventricular (LV)-body weight ratio was increased in the diabetic group and was unaffected by treatment with ET antagonist. mRNA expression of VEGF and its receptors (Flt-1 and Flk-1) in the LV tissues was assessed using real-time polymerase chain reaction. VEGF expression was significantly decreased in diabetic heart and was greatly improved by treatment with ET antagonist. The expression of VEGF receptors was down-regulated in early diabetic heart but was not recovered by treatment with ET antagonist. ET and its receptor A might have differential regulation on the gene expressions of VEGF and its receptors in early diabetic heart.     

The Effects of Empagliflozin,an SGLT2 Inhibitor,on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes

The novel sodium glucose co-transporter 2 (SGLT2) inhibitor empagliflozin has recently been reported to improve glycemic control in streptozotocin-induced type 1 diabetic rats in an insulin-independent manner, via an increase in urinary glucose output. We investigated the potential of empagliflozin to recover insulin pathways in type 1 diabetes by improving pancreatic β-cell mass. Blood glucose homeostasis was assessed by an intraperitoneal glucose tolerance test. Serum insulin levels and insulin mRNA expression were determined using commercial insulin ELISA kits and real-time quantitative polymerase chain reaction, respectively. Immunohistochemistry was used to investigate β-cell areas, β-cell proliferation, apoptosis of pancreatic β-cells, and reactive oxygen species production in the pancreatic β-cells. Results showed that glucose tolerance was significantly improved in streptozotocin-induced type 1 diabetic mice treated with empagliflozin. Empagliflozin-treated mice also showed an increase in insulin mRNA expression. Higher serum insulin levels were detected in mice treated with empagliflozin compared with the vehicle group. Immunohistochemistry indicated that β-cell area/total pancreatic area and the expression of cell proliferation marker Ki-67 (co-stained with insulin) were significantly enhanced by empagliflozin treatment. These effects were due, probably, to a reduction in apoptosis and reactive oxygen species in the pancreatic β-cells. Taken together, the results of this study indicate that empagliflozin may have a beneficial effect on preserving β-cell regeneration, thus improving blood glucose homeostasis in type 1 diabetes mellitus, probably via the protection of pancreatic β-cell from glucotoxicity-induced oxidative stress.     

血红素加氧酶／一氧化碳系统在1，6-二磷酸果糖抗IL-1β致胰岛细胞凋亡中的作用

目的：探讨1,6-二磷酸果糖（FDP）对白介素-1β（IL-1β）致胰岛细胞凋亡的保护作用及其机制与血红素加氧酶／一氧化碳（HO-1／CO）系统的关系。方法：应用离体培养乳鼠的胰岛细胞,分别检测IL-1β、FDP作用后细胞形态、细胞活性、细胞凋亡率、细胞HO-1的活性和细胞培养上清液中胰岛素的基础和高糖刺激分泌量以及CO的含量的变化,同时设立正常对照组。结果：正常胰岛细胞HO-1活性较低,CO含量少,凋亡细胞率为4．71±0．62。IL-1β作用20h后,与正常组比较胰岛细胞活性明显降低,基础和高糖刺激胰岛素分泌减少,胰岛细胞凋亡率明显增加（P〈0．01）;细胞HO-1活性有所增加,上清液中CO生成增多（P〈0．05）,损伤后与FDP共同孵育细胞活性显著升高,胰岛素基础和高糖分泌量增多,胰岛凋亡率明显降低,HO-1活性和CO生成显著提高（P〈0．01）,具有统计学意义。结论：FDP能降低IL-1β诱导胰岛细胞的凋亡,改善细胞活性,促进细胞的分泌功能,机制可能与FDP增加HO-1活性,从而CO生成增多有关。